Dylan Supina

Dylan Supina has extensive work experience in the pharmaceutical industry, specializing in health economics, outcomes research, and market access. Dylan is currently a Senior Director at Geron Corporation, where they oversee real-world evidence analytics and strategy. Before joining Geron, Dylan worked as the Director of Health Economics and Outcomes Research at Jazz Pharmaceuticals from 2020 to 2022. Prior to that, they were the Director of Global Evidence and Market Access at CSL Behring from 2018 to 2020. Dylan also served as the Principal of Main Line Analysis LLC from 2015 to 2018 and the Director of Global Health Economics and Outcomes Research at Shire Pharmaceuticals from 2011 to 2015. Before that, they held positions at Johnson & Johnson and Wyeth Pharmaceuticals.

Dylan Supina holds a Bachelor's Degree in Economics from Virginia Tech and is pursuing a Doctor of Philosophy (Ph.D.) in Economics from Penn State University.